These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

570 related items for PubMed ID: 16234511

  • 1. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES.
    J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511
    [Abstract] [Full Text] [Related]

  • 2. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 3. Risk-adapted approach for fever and neutropenia in paediatric cancer patients--a national multicentre study.
    Miedema KG, Tissing WJ, Abbink FC, Ball LM, Michiels EM, van Vliet MJ, de Vries WY, Kamps WA, Norbruis OF, Fiocco M, de Groot-Kruseman HA, van de Wetering MD, de Bont ES.
    Eur J Cancer; 2016 Jan 01; 53():16-24. PubMed ID: 26700076
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.
    Ann Hematol; 2007 Apr 01; 86(4):263-70. PubMed ID: 17225113
    [Abstract] [Full Text] [Related]

  • 8. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 9. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.
    N Engl J Med; 1999 Jul 29; 341(5):305-11. PubMed ID: 10423464
    [Abstract] [Full Text] [Related]

  • 11. Risk assessment in fever and neutropenia in children with cancer: What did we learn?
    te Poele EM, Tissing WJ, Kamps WA, de Bont ES.
    Crit Rev Oncol Hematol; 2009 Oct 29; 72(1):45-55. PubMed ID: 19195908
    [Abstract] [Full Text] [Related]

  • 12. Risk index for predicting complications and prognosis in Thai patients with neutropenia and fever.
    Chayakulkeeree M, Thamlikitkul V.
    J Med Assoc Thai; 2003 Mar 29; 86(3):212-23. PubMed ID: 12757060
    [Abstract] [Full Text] [Related]

  • 13. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R, Görgün O, Ayan I, Gürler N, Akici F, Töreci K.
    Med Pediatr Oncol; 2001 Apr 29; 36(4):434-41. PubMed ID: 11260566
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
    McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A.
    Gynecol Oncol; 1996 Aug 29; 62(2):247-53. PubMed ID: 8751557
    [Abstract] [Full Text] [Related]

  • 16. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
    Ammann RA, Hirt A, Lüthy AR, Aebi C.
    Med Pediatr Oncol; 2003 Nov 29; 41(5):436-43. PubMed ID: 14515382
    [Abstract] [Full Text] [Related]

  • 17. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A.
    Pediatr Blood Cancer; 2007 Nov 29; 49(6):786-92. PubMed ID: 17366527
    [Abstract] [Full Text] [Related]

  • 18. The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia.
    Tromp YH, Daenen SM, Sluiter WJ, Vellenga E.
    Eur J Cancer; 2009 Mar 29; 45(4):596-600. PubMed ID: 19095436
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR.
    J Clin Oncol; 2004 Aug 15; 22(16):3350-6. PubMed ID: 15310780
    [Abstract] [Full Text] [Related]

  • 20. Evolving concepts of management of febrile neutropenia in children with cancer.
    Orudjev E, Lange BJ.
    Med Pediatr Oncol; 2002 Aug 15; 39(2):77-85. PubMed ID: 12116054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.